LIGAND PHARMACEUTICALS INC
Insider CIK 886163 · VKTX 10% owner · NONE 10% owner · PTHS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PTHS Pelthos Therapeutics Inc. | A Award deriv | 2025-12-17 | 2025-12-19 | 0 | — | $0 | 0 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | D To issuer deriv | 2025-12-17 | 2025-12-19 | 0 | — | $0 | 0 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | A Award deriv | 2025-11-06 | 2025-11-10 | 0 | $9000000.00 | $0 | 0 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | C Conversion deriv | 2025-07-01 | 2025-07-03 | 15,000 | — | $0 | 3,000 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | J Other deriv | 2025-07-01 | 2025-07-03 | 31,279 | — | $0 | 34,279 | SEC↗ |
| PTHS Pelthos Therapeutics Inc. | C Conversion | 2025-07-01 | 2025-07-03 | 1,500,000 | $10.00 | $15.00M | 1,500,000 | SEC↗ |
| NONE OmniAb Operations, Inc. | J Other | 2022-11-01 | 2022-11-03 | 16,859,308 | — | $0 | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2020-08-26 | 2020-08-27 | 94,488 | $8.11 | $766.3K | 5,819,383 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2020-08-26 | 2020-08-28 | 148,700 | $8.11 | $1.21M | 5,819,383 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2020-08-25 | 2020-08-27 | 70,000 | $8.02 | $561.4K | 5,968,083 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | S Sale | 2018-09-25 | 2018-09-27 | 262,881 | $19.15 | $5.03M | 6,038,083 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | J Other deriv | 2018-05-21 | 2018-09-27 | 1,916,509 | $1916509.00 | $3673.01B | 0 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | J Other deriv | 2017-07-13 | 2018-09-27 | 38,630 | $38630.00 | $1.49B | 1,916,509 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | J Other deriv | 2016-04-13 | 2016-04-15 | 150,000 | $150000.00 | $22.50B | 1,955,139 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | C Conversion deriv | 2016-04-13 | 2016-04-15 | 960,000 | — | $0 | 1,520,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | C Conversion deriv | 2016-04-13 | 2016-04-15 | 600,000 | $1.25 | $750.0K | 2,105,139 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award deriv | 2016-04-13 | 2016-04-15 | 560,000 | — | $0 | 560,000 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | A Award | 2016-04-13 | 2016-04-15 | 560,000 | — | $0 | 5,340,964 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | C Conversion | 2016-04-13 | 2016-04-15 | 960,000 | $1.25 | $1.20M | 6,300,964 | SEC↗ |
| VKTX Viking Therapeutics, Inc. | J Other | 2015-05-28 | 2015-06-01 | 228,105 | — | $0 | 4,780,964 | SEC↗ |